Mesalamine to Reduce T Cell Activation in HIV Infection

Clinical trial NCT01090102 · COMPLETED

Trial details

NCT number: NCT01090102
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV Infections Sexually Transmitted Diseases Immune System Diseases Lentivirus Infections Acquired Immunodeficiency Syndrome

Start date: 2010-06-01
Primary completion: 2012-12-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.